Search Results

You are looking at 1 - 10 of 14 items for :

  • Framingham risk score x
  • Molecular Biology x
Clear All
Open access

Snežana Jovičić, Svetlana Ignjatović and Nada Majkić-Singh

-10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24 : 987-1003. National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). http://hin.nhlb.nih.gov/atpiii/calculator.asp?usertype=prof Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet

Open access

Snežana Jovičić

inhibits three steps in the formation of mildly oxidized low density lipoprotein. J Lipid Res 2000; 41: 1481-508. Vega GL, Grundy SM. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 1996; 7: 209-16. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994

Open access

Nevena Eremić and Mirjana Đerić

Cholesterol Education Program Adult Treatment Panel III Guidelines. JACC 2004; 44 (3): 720-32. National Heart Lung and Blood Institute. Framingham Heart Study. http://www.nhlbi.nih.gov/about/framingham/index.html Sarti C, Gallagher J. The metabolic syndrome. J Diabetes Complicat 2006; 20 (2): 121-32. Assman G, Cullen P, Shulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study

Open access

Grazyna Sypniewska, Katarzyna Bergmann, Magdalena Krintus, Marek Kozinski and Jacek Kubica

Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008; 51: 1512-24. Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small lowdensity lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006; 113: 20-9. Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. QJM 2006; 99: 277-87. Eremić N, Đerić M. Evaluation of coronary risk score applications in 10-yaer coronary

Open access

Vesna Vuković-Dejanović, Nataša Bogavac-Stanojević, Slavica Spasić, Vesna Spasojević-Kalimanovska, Dimitra Kalimanovska-Oštrić, Mirko Topalović and Zorana Jelić-Ivanović

coronary artery disease by using Framingham Risk Score (FRS). J An Bio-Sci 2011; 34: 324–30. 35. Koenig W, Löwel H, Baumert J, Meisinger C. Baumert and Christa Meisinger. C-Reactive Protein modulates risk prediction based on the Framingham Score: Implications for future risk assessment: Results from a large cohort study in Southern Germany. Circulation 2004; 109: 1349–53. 36. Cristell N, Cianflone D, Durante A, Ammirati E, Vanuzzo D, Banfi M, et al. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation

Open access

Aleksandra Stefanović, Danijela Ristovski-Kornic, Jelena Kotur-Stevuljević, Vesna Spasojević-Kalimanovska, Jelena Vekić, Milica Miljković, Dusan Paripović, Amira Peco-Antic, Zorana Jelić-Ivanović and Aleksandra Zeljković

HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 2007; 40: 310-6. 16. Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 2008; 23: 2461-6. 17. Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreo KE. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Athero - sclerosis 2010; 208: 3-9. 18. Zeljkovic A, Vekic J

Open access

Bosa Mirjanić-Azarić, Zorana Jelić-Ivanović, Aleksandra Zeljković, Jelena Vekić, Günther Jürgens, Tatjana Milivojac, Sanja Avram, Jozo Ćorić, Janja Marc and Darko Černe

data by quantitative real-time RT PCR. J Med Biochem 2013; 32: 325-38. 16. Rainwater DL, Andres DW, Ford AL, Lowe WF, Blanche PJ, Krauss RM. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. J Lipid Res 1992; 33: 1876 81. 17. Vekić J, Topić A, Zeljković A, Jelić-Ivanović Z, Spa - sojević-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middleaged Serbian population. Clin Biochem 2007; 40: 310-6. 18. Zeljković A, Spasojević

Open access

Olga Vasović, Katarina Lalić, Danijela Trifunović, Nataša Milić, Ivan Jevremović, Ljiljana Popović, Dalibor Paspalj, Aleksandra Milićević-Kalasić, Goran Ševo, Nebojša Despotović, Predrag Erceg and Dragoslav P. Milosevic

. Kidney Int 2008; 73(4): 391-8. 15. Filippatos GS, Desai RV, Ahmed MI, Fonarow GC, Love TE, Aban IB, Iskandrian AE, Konstam MA, Ahmed A. Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail 2011; 13(10): 1078-86. 16. Kinugasa Y, Kato M, Sugihara S, Hirai M, Kotani K, Ishida K, Yanagihara K, Kato Y, Ogino K, Igawa O, Hisa tome I, Shigemasa C. A Simple Risk Score to Predict In-Hospital Death of Elderly Patients With Acute De com pen sated Heart Failure. Hypoalbuminemia as an Addi tional Prog - nostic Factor. Circ J

Open access

Michael Vogeser and Christoph Seger

strategies to maintain adequacy of circulating 25-hydroxyvitamin D concentrations. Scand J Clin Lab Invest 2012; 72: Suppl 243: 14-23. 36. Liu E, McKeown NM, Pittas AG, Meigs JB, Economos CD, Booth SL, et al. Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study. Eur J Clin Nutr 2012; 66(1): 139-41. 37. O'Donnell S, Cranney A, Horsley T, Weiler HA, Atkinson SA, Hanley DA, et al. Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review. Am J Clin Nutr

Open access

Irina Juhas, Branko Skof, Dejana Popović, Milan Matić and Nenad Janković

, psychosocial and educational status of the student population in the Republic of Serbia« which is financed by Ministry of Education and Science of the Republic of Serbia. Conflict of interest Conflict of interest statement: The authors stated that they have no conflicts of interest regarding the publication of this article. References 1 Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D’Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004; 94(1): 20–4. 10.1016/j.amjcard.2004